THURSDAY, Oct. 29, 2020 — An Eli Lilly-developed COVID-19 antibody drug that didn’t help hospitalized patients might still prove effective in treating people with mild or moderate infections,
Spatial repellents can reduce the risk of people becoming infected with Aedes mosquito-borne viruses, according to new results of a clinical trial conducted in Iquitos, Peru. Results of
Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications, were less likely to die from cancer. The analysis was published in the
A new review provides reassurance to patients who have missed routine dental check-ups due to COVID-19 restrictions by showing that six-monthly check-up appointments do not improve oral health.
Researchers at the University of Illinois, Urbana-Champaign, Abbott and, the U.S. Air Force Research Lab announced today the results of a new study that found a direct link
An international research team has analyzed the health records of more than 45,000 people with diabetes in New Zealand over approximately 25 years—exposing the full extent of the
BREAKING NEWS: Remdesivir has ‘little effect’ on COVID-19 death risks, WHO study study finds The antiviral remdesivir is one of just two COVID-19 treatments that has emergency FDA
A hormone that influences when and how frequently animals eat also appears to affect memory, USC scientists have found. Animals and humans have the hormone ghrelin in their
Several predictions made by experts ahead of the UK-wide lockdown in March are confirmed in a detailed re-analysis of the data published by The BMJ today. A report
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
